Search results
Results From The WOW.Com Content Network
The falling share price has pushed the stock's dividend yield to nearly 6%. ... In other words, Pfizer's next growth phase could already be starting. This growth should support the dividend.
The good news on this front, though, is that Pfizer is poised to improve its bottom line and make its dividend even safer. Sure, the big pharma company's earnings fell 11% year over year in Q2.
Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield -- the highest among major drug manufacturers and one of the ...
Pfizer's stock price was hammered, but that didn't prevent the company from meeting and raising its dividend commitment. Last December, the pharmaceutical company raised its payout for the 15th ...
A high-yield dividend stock with long-term potential Pfizer's current 5.73% dividend yield stands well above the S&P 500 average of 1.35%. The company's payout ratio of 443% appears unsustainable ...
For premium support please call: 800-290-4726 more ways to reach us
The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. See the 10 stocks » *Stock Advisor returns as of June 10, 2024. George Budwell has positions in Pfizer. The ...
Pfizer stock currently has a 5.9% dividend yield, making it an attractive target for income investors. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways to ...